verified SJR 0,253 · Q4 • database Scopus / SJR & Web of Science indexed

United Kingdom · Taylor and Francis Ltd.

workspace_premium Q4 — Neurology (clinical) lock Subscription Unclaimed

Future Neurology

Future Neurology is a journal indexed in SJR in Neurology (clinical) and Neurology with an H index of 39. It has a price of 2083 €. It has an SJR impact factor of 0,253 and it has a best quartile of Q4. It has an SJR impact factor of 0,253.

ISSN: 1479-6708

Editorial: Taylor and Francis Ltd.

Category: Neurology (clinical)

Indexation: verifiedScopus / SJR verifiedWeb of Science

Unclaimed profile — some fields may be incomplete.

open_in_new Portal NPD menu_book Guidelines NPD

schedule Datos CoP · solo campos en BD

SJR Impact Factor trending_up

0,253 Q4

H-index 39

Tasa de Aceptación pie_chart

35%

Fuente Acceptance_Rate

Tiempo a publicación hourglass_top

NPD

Campo Sin dato

Coste de Publicación (APC) payments

2.083 € Subscription

Ruta Non-OA NPD

Metrics

Campos Scimago / CoP — sin series inventadas

Scopus / SJR Web of Science

SJR Impact

0,253

H-index

Docs (year)

Docs 3y

Total refs

238

Cites 3y

Citable 3y

Cites/Doc 2y

0.28

Ref/Doc

23.8

Immediate OA

2083 €

Embargoed OA

NPD

Non OA / Submission

—

shield Researcher voice

Name good journals. Call out predatory ones.

Share what peer review, fees, and timelines were really like. Praise fair editors. Flag APC traps, fake metrics, or spam solicitations — with facts from your submission.

Fair & fast peer review Clear APC / no surprise fees Suspected predatory Fake impact claims

rate_review Write an honest review

Researcher reviews

sentiment_dissatisfied No reviews yet — be the first to share an honest experience.

Publication speed *

Review quality *

Edition and editorial team *

Institutional email or ORCID * * Only to validate authenticity — identity is not shown publicly.

Best articles by citations

Blood vessels in neurological development and disease: more than silent spectators

Vortioxetine in the treatment of major depressive disorder

Evidence-to-practice gaps in post-stroke management: a focus on care in a stroke unit and anticoagulation to prevent death, disability and recurrent stroke

Endocannabinoids and fetal organ development: a conflict of misconstrued concepts and policies?

Emerging themes from the literature on circulating biomarkers of traumatic brain injury

Disease-modifying therapy for multiple sclerosis

Diagnosis of schizophrenia: a 19th Century concept not fit for 21st Century science

Current developments in MRI for assessing rodent models of multiple sclerosis

Conquering the barriers: are antibody therapeutics feasible for CNS indications?

Clazosentan: a review of subarachnoid hemorrhage data

Cell transplantation for Huntington's disease: practical and clinical considerations

British Paediatric Neurology Association 32nd Annual Conference

SHOW MORE ARTICLES

Brain lesions and emotional disorders

Acamprosate in the treatment of alcoholism: mechanisms and perspectives

Biomarkers to advance drug development for Alzheimer's disease

Biogenesis and regulation of microRNA: implication in Alzheimer's disease

Autologous hematopoietic stem cell transplantation: a cure for multiple sclerosis?

Autoimmune limbic encephalitis

Atomoxetine in clinical practice

Aripiprazole: a new treatment for schizophrenia

Antidepressant-coincident mania in children and adolescents treated with selective serotonin reuptake inhibitors

Alzheimer's disease and schizophrenia: evidence of a specific, shared molecular background

Agrin in the nervous system: synaptogenesis and beyond

ADAM10: potential 'molecular scissors' for the treatment of Alzheimer's disease

FAQS

In Country of Papers you can find SJR impact factor and other metrics to help you decide on a Journal.